Cardiorespiratory Fitness Linked to Psoriasis, Psoriatic Arthritis
FRIDAY, Jan. 15, 2021 -- Low cardiovascular fitness in late adolescence is associated with an increased risk for incident psoriasis and psoriatic arthritis among men, according to a study published online Jan. 11 in PLOS ONE. Marta Laskowski, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 15, 2021 Category: Pharmaceuticals Source Type: news

Echo helps identify flossing-induced heart disease
In a case report from Texas, echocardiography helped clinicians diagnose a...Read more on AuntMinnie.comRelated Reading: Echocardiography shows range of COVID-19 heart injuries Ultrasound shows heart disease risk from psoriasis Researchers test new ultrasound method for heart disease New ultrasound technique gauges kids' heart function Stress echo beats CCTA for evaluating chest pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 11, 2021 Category: Radiology Source Type: news

High cholesterol warning: Psoriasis symptoms could be a visual sign of high cholesterol
HIGH CHOLESTEROL can increase your risk of heart and circulatory diseases so it is vital to lower your levels. The condition doesn't usually present any warning signs but a study suggests psoriasis symptoms may signal you have too much cholesterol in your blood. (Source: Daily Express - Health)
Source: Daily Express - Health - January 6, 2021 Category: Consumer Health News Source Type: news

Heart Risk Factors May Be Especially Unhealthy in People With Psoriasis
MONDAY, Jan. 4, 2021 -- People with metabolic syndrome and the skin condition psoriasis are at especially high risk for heart attack and stroke, a new study warns. Psoriasis has been known to increase the risk of heart disease, but researchers have... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 4, 2021 Category: General Medicine Source Type: news

Heart Risk Factors May Be Especially Unhealthy in People With Psoriasis
Title: Heart Risk Factors May Be Especially Unhealthy in People With PsoriasisCategory: Health NewsCreated: 1/4/2021 12:00:00 AMLast Editorial Review: 1/4/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 4, 2021 Category: Cardiology Source Type: news

Cardiovascular Risk Up With Metabolic Syndrome in Psoriasis
WEDNESDAY, Dec. 30, 2020 -- Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk, according to a study published online Dec. 28 in the Journal of the American Academy of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 30, 2020 Category: Pharmaceuticals Source Type: news

Study: Psoriasis, metabolic syndrome combo may increase heart disease risk
The presence of metabolic syndrome in people with psoriasis may contribute to an increased risk of heart disease, according to a study published Monday by the Journal of the American Association of Dermatology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 28, 2020 Category: Consumer Health News Source Type: news

Patients With Psoriasis Shoulder Substantial Psychological Burden
MONDAY, Dec. 28, 2020 -- Patients with psoriasis have a considerable psychological burden, according to a study published online Dec. 22 in The Journal of Dermatology. Wiebke Sondermann, M.D., from the University Hospital Essen in Germany, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2020 Category: Pharmaceuticals Source Type: news

Study links metabolic syndrome to higher cardiovascular risk in patients with psoriasis
Metabolic syndrome affects about 25% of adults and is on the rise, and its prevalence is even greater among patients with psoriasis. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 28, 2020 Category: American Health Source Type: news

Secukinumab in children with plaque psoriasis: Study unsuitable for benefit assessment
(Institute for Quality and Efficiency in Health Care) Secukinumab in children with plaque psoriasis: study unsuitable for benefit assessmentThe comparator group was not treated appropriately. Firstly, therapy in this group remained unchanged despite non-response, and secondly, it was continued for longer than approved. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2020 Category: International Medicine & Public Health Source Type: news

Adverse Pregnancy Outcomes Up for Women With Psoriasis
MONDAY, Nov. 30, 2020 -- Pregnancies in women with psoriasis have an increased risk for adverse outcomes, including preeclampsia and stillbirth, according to a study published online Nov. 18 in the Journal of Dermatology. Yu-Heui Huang, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2020 Category: Pharmaceuticals Source Type: news

T-ray technology reveals what's getting under your skin
(University of Warwick) A new method for analysing the structure of skin using a type of radiation known as T-rays could help improve the diagnosis and treatment of skin conditions such as eczema, psoriasis and skin cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 26, 2020 Category: Biology Source Type: news

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years
The full 5-year results of a study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5400 patient-years of follow-up.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 21, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Skin health: The best and worst foods for acne, psoriasis and skin disease
SKIN health: According to experts and studies, a person can eat themselves beautiful. In fact, eating the right kinds of food will not only make your skin glow, but it will also help with overall health and reduce the risk of acne, psoriasis and some skin diseases. What should be eaten and what should be avoided? (Source: Daily Express - Health)
Source: Daily Express - Health - November 19, 2020 Category: Consumer Health News Source Type: news

Ustekinumab for Plaque Psoriasis in Pediatric Patients Ustekinumab for Plaque Psoriasis in Pediatric Patients
Ustekinumab is currently approved for the treatment of moderate-to-severe plaque psoriasis in adolescents and adults; is it safe for younger patients?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Finnish digital health startup Popit partners with pharma firm Almirall to support psoriasis patients
The solution to aid medication adherence has launched in The Netherlands. (Source: mobihealthnews)
Source: mobihealthnews - November 12, 2020 Category: Information Technology Source Type: news

Topical Tapinarof Effective in Pivotal Psoriasis Trials Topical Tapinarof Effective in Pivotal Psoriasis Trials
Tapinarof cream 1% applied once daily in patients with plaque psoriasis convincingly hit its primary and secondary endpoints and was well tolerated in two identical pivotal phase 3, randomized trials.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 6, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Biologics May Protect Patients With Psoriasis Against Severe COVID Biologics May Protect Patients With Psoriasis Against Severe COVID
This apparent protective effect of biologic agents against severe COVID-19 is even more impressive because the psoriasis patients in this study had relatively high rates of obesity, smoking, and COPD.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 3, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Mirikizumab Beats Placebo, Secukinumab for Psoriasis Mirikizumab Beats Placebo, Secukinumab for Psoriasis
52-week trial data pitting an interleukin-23 drug against an IL-17 inhibitor and placebo offers insight on efficacy and safety.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 2, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Is it eczema or psoriasis? How to tell the difference between the two skin conditions
ECZEMA and psoriasis may be confused as one another, but both skin conditions require different treatments. This is why it's important to determine which one you have. (Source: Daily Express - Health)
Source: Daily Express - Health - October 30, 2020 Category: Consumer Health News Source Type: news

Smoking Has Negative Effects for Patients With Psoriasis
FRIDAY, Oct. 30, 2020 -- For patients with psoriasis, smoking has negative effects, including increased frequency of nail involvement and cardiovascular diseases and higher psoriasis area and severity index, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2020 Category: Pharmaceuticals Source Type: news

Smoking Has Negative Effects for Patients With Psoriasis
Title: Smoking Has Negative Effects for Patients With PsoriasisCategory: Health NewsCreated: 10/30/2020 12:00:00 AMLast Editorial Review: 10/30/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - October 30, 2020 Category: Respiratory Medicine Source Type: news

Los medicamentos para la psoriasis no aumentan el riesgo de una COVID-19 grave, seg ún un estudio
MARTES, 27 de octubre de 2020 -- Unos investigadores de Reino Unido tienen unas noticias tranquilizadoras para las personas con psoriasis, bas ándose en el primer análisis de un registro global de la COVID-19 de pacientes que también tienen la... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 29, 2020 Category: Pharmaceuticals Source Type: news

New evidence shows microbe strain can orally treat systemic inflammation in psoriasis
(Say Communications) New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 29, 2020 Category: International Medicine & Public Health Source Type: news

Psoriasis Meds Don't Raise Risk of Severe COVID-19
Moderate-to-severe cases of psoriasis are treated with drugs that suppress the immune system. This analysis of the international PsoProtect registry found that more than 90% of psoriasis patients survive infection with the new coronavirus. (Source: WebMD Health)
Source: WebMD Health - October 27, 2020 Category: Consumer Health News Source Type: news

Psoriasis Meds Don't Raise Risk of Severe COVID-19: Study
TUESDAY, Oct. 27, 2020 -- Researchers in the United Kingdom have reassuring news for people with psoriasis based on the first analysis of a global registry of COVID-19 patients who also have the skin disease. Moderate-to-severe cases of psoriasis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 27, 2020 Category: General Medicine Source Type: news

Psoriasis Meds Don't Raise Risk of Severe COVID-19: Study
Title: Psoriasis Meds Don't Raise Risk of Severe COVID-19: StudyCategory: Health NewsCreated: 10/27/2020 12:00:00 AMLast Editorial Review: 10/27/2020 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - October 27, 2020 Category: Dermatology Source Type: news

Taking the itch out of cancer immunotherapy
(University of Tsukuba) Researchers from the University of Tsukuba have determined that PD-1 expression on CD8 T cells is the biological pathway that leads to psoriasis-like dermatitis, an unfavorable side effect of cancer immunotherapy with PD-1 inhibitors. This finding offers hope that blocking this pathway can prevent or reduce the undesirable side effect and help cancer patients continue their treatment with improved quality-of-life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2020 Category: Cancer & Oncology Source Type: news

Survival From COVID-19 High in Patients With Psoriasis
FRIDAY, Oct. 23, 2020 -- For patients with psoriasis, survival from COVID-19 is high, with increased hospitalization risk in association with nonbiologic systemic therapy versus biologic use, according to a study published online Oct. 16 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 23, 2020 Category: Pharmaceuticals Source Type: news

Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials
Participation by non-White patients in phase 3 therapeutic trials for plaque psoriasis is less than 15%.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 21, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Most psoriasis patients taking immunosuppressants survive COVID-19
(National Institute for Health Research) Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 20, 2020 Category: Infectious Diseases Source Type: news

Life Experiences of Psoriasis Patients Receiving Biologics Life Experiences of Psoriasis Patients Receiving Biologics
While biologics have improved treatment outcomes and health-related quality of life in patients with psoriasis, this study reveals that psychological issues caused by psoriasis persist.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Johnson & Johnson Reports 2020 Third-Quarter Results
New Brunswick, N.J. (October 13, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. “Our third-quarter results reflect solid performance and positive trends across Johnson & Johnson, powered by better-than-expected procedure recovery in Medical Devices, growth in Consumer Health, and continued strength in Pharmaceuticals,” said Alex Gorsky, Chairman and Chief Executive Officer. “I am proud of the relentless passion and Credo-led commitment to patients and customers that our colleagues around the world continue to demonstrate as we boldly fight the COVID-19 ...
Source: Johnson and Johnson - October 13, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

The Differences Between White and Latino Patients With Psoriasis The Differences Between White and Latino Patients With Psoriasis
Differences in the patterns of disease did reach significance.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 8, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

Dermatologists' perceptions of suicidality in dermatological practice: a survey of prevalence estimates and attitudes in Austria - Pronizius E, Voracek M.
BACKGROUND: Chronic illnesses belong to suicide risk factors. The goal of the current study was to estimate the rate of suicide-related behaviors in patients with atopic dermatitis, psoriasis, or acne from a third-person perspective (namely, Austrian derma... (Source: SafetyLit)
Source: SafetyLit - October 3, 2020 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Pregnancy Studies on Psoriasis, PsA Medications Pick Up Pregnancy Studies on Psoriasis, PsA Medications Pick Up
Pregnancy outcomes data are increasingly emerging but dermatologists, rheumatologists, and their female patients with psoriasis and psoriatic arthritis (PsA) want much more.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 2, 2020 Category: Dermatology Tags: Ob/Gyn & Women ' s Health News Source Type: news

SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

Kids Who Need Steroids Face Risk of Diabetes, Other Ills
THURSDAY, Sept. 24, 2020 -- Children who need to take oral steroids for chronic or life-threatening conditions can experience serious side effects, according to new research. Children with autoimmune disorders such as juvenile arthritis, psoriasis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 24, 2020 Category: General Medicine Source Type: news

Sun Pharma arm launches plaque psoriasis treatment drug in Japan
In a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection 100 mg Syringe in Japan for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2020 Category: Pharmaceuticals Source Type: news

Association between psoriasis and depression: a traditional review - Sahi FM, Masood A, Danawar NA, Mekaiel A, Malik BH.
Psoriasis is a chronic inflammatory disease of the skin with multiple comorbidities, depression being one of them. Psoriasis affects the personal, social, and sexual lives of the patients resulting in psychological strain.   Psoriasis and depression amplif... (Source: SafetyLit)
Source: SafetyLit - September 21, 2020 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Impact of Psoriasis Explored for Hospital Outcomes of Acute MI
MONDAY, Sept. 21, 2020 -- Myocardial infarction (MI) events may occur earlier in life in patients with psoriasis, which in turn may affect hospital outcomes, according to a study published online Sept. 11 in the Journal of the American Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2020 Category: Pharmaceuticals Source Type: news

Depression Common Among Psoriasis Patients
Women, patients younger than 30 years have higher rates of depression (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 18, 2020 Category: Psychiatry Tags: Dermatology, Family Medicine, Gynecology, Internal Medicine, Pharmacy, Psychiatry, Institutional, Source Type: news

Depression Common Among Psoriasis Patients
FRIDAY, Sept. 18, 2020 -- Depression is common among patients with psoriasis, according to a study published online Sept. 14 in Dermatology. Albert Duvetorp, from Skåne University Hospital in Malmö, Sweden, and colleagues used data from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Biologics for Psoriasis May Also Reduce Coronary Plaque Biologics for Psoriasis May Also Reduce Coronary Plaque
Biologics used as treatment for psoriasis could also help reduce lipid-rich necrotic core, a high-risk plaque associated with cardiovascular events, a prospective, observational study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 17, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Some Psoriasis Meds May Also Help Prevent Heart Disease
Title: Some Psoriasis Meds May Also Help Prevent Heart DiseaseCategory: Health NewsCreated: 9/15/2020 12:00:00 AMLast Editorial Review: 9/16/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 16, 2020 Category: Cardiology Source Type: news

Some Psoriasis Meds May Also Help Prevent Heart Disease
Chronic inflammation in people with psoriasis is associated with the development of plaque in heart arteries, which increases the risk of coronary artery disease. In biologic therapy, patients receive protein-based infusions to reduce inflammation. (Source: WebMD Health)
Source: WebMD Health - September 15, 2020 Category: Consumer Health News Source Type: news

Some Psoriasis Meds May Also Help Prevent Heart Disease
TUESDAY, Sept. 15, 2020 -- Biologic therapy for the skin condition psoriasis may reduce patients'risk of heart disease, new research suggests. Chronic inflammation in people with psoriasis is associated with the development of plaque in heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2020 Category: General Medicine Source Type: news

Lipid-Rich Necrotic Core Linked to Psoriasis Severity
TUESDAY, Sept. 15, 2020 -- For patients with psoriasis, lipid-rich necrotic core (LRNC) is associated with psoriasis severity and cardiovascular risk factors and is reduced for those patients receiving biologic therapy, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 15, 2020 Category: Pharmaceuticals Source Type: news

How to Get Rid of Psoriasis Quickly
Title: How to Get Rid of Psoriasis QuicklyCategory: Diseases and ConditionsCreated: 9/15/2020 12:00:00 AMLast Editorial Review: 9/15/2020 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 15, 2020 Category: Dermatology Source Type: news

Biologic therapy for psoriasis may reduce heart disease
(American Heart Association) Biologic therapy for psoriasis - protein-based infusions to suppress inflammation - was associated with a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research.The positive association between biologic therapy and a decrease in high-risk plaque in heart arteries was significant after adjusting for cardiovascular risk factors and psoriasis severity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 15, 2020 Category: International Medicine & Public Health Source Type: news